Photo by YouTube screen capture

Photo by YouTube screen capture

View original image


[Asia Economy Reporter Kim Heung-soon] A study has found that the antiparasitic drug "Ivermectin," approved by the U.S. Food and Drug Administration (FDA), kills the novel coronavirus (COVID-19) within 48 hours. This result comes from cell culture experiments, and it remains uncertain whether it will be effective in clinical trials involving patients.


On the 4th, the U.S. science media Science Daily reported this experimental result citing Dr. Kylie Wagstaff of the Monash University Institute of Biomedical Discovery in Australia.


According to the study, the COVID-19 virus cultured in cells was completely eliminated within 48 hours after exposure to Ivermectin, and even a single dose significantly reduced the viral genome (RNA) of COVID-19 after 24 hours.


However, Dr. Wagstaff emphasized, "Since these results come from cell culture experiments, clinical trials on humans are necessary." She added, "Although Ivermectin is considered a widely used and safe drug, it is essential first to determine the appropriate dosage required to be effective for patients infected with COVID-19."



According to the report, although Ivermectin is approved as an antiparasitic drug, it has also been found to be effective against a broad range of viruses, including AIDS, dengue fever, influenza, and Zika virus.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing